Ultragenyx Pharmaceutical Inc (RARE) insider trading
Every open-market stock purchase and sale by Ultragenyx Pharmaceutical Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $3.6M over the last 12 months (20 sales). No open-market buys.
- Last insider buy: Emil D Kakkis (CEO), $218K, 7 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $3.6M (20 sales). Last close $24.85 on Jun 16, 2026.
Recent RARE insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 15, 2026 | Corazon (Corsee) D. Sanders (Insider) | Sold | $50.1K |
| Jun 15, 2026 | Karah Herdman Parschauer (C-suite exec) | Sold | $46.8K |
| Jun 1, 2026 | Howard Horn (CFO) | Sold | $111K |
| May 18, 2026 | Shehnaaz Suliman (Insider) | Sold | $144K |
| May 14, 2026 | Corazon (Corsee) D. Sanders (Insider) | Bought (not open market) | — |
| May 14, 2026 | Matthew K Fust (Insider) | Bought (not open market) | — |
| May 14, 2026 | Michael Narachi (Insider) | Bought (not open market) | — |
| May 14, 2026 | Shehnaaz Suliman (Insider) | Bought (not open market) | — |
| May 14, 2026 | Deborah Dunsire (Insider) | Bought (not open market) | — |
| May 14, 2026 | Shehnaaz Suliman (Insider) | Bought (not open market) | — |
| May 14, 2026 | Matthew K Fust (Insider) | Bought (not open market) | — |
| May 14, 2026 | Amrit Ray (Insider) | Bought (not open market) | — |
| May 14, 2026 | Michael Narachi (Insider) | Bought (not open market) | — |
| May 14, 2026 | Daniel G Welch (Insider) | Bought (not open market) | — |
| May 14, 2026 | Daniel G Welch (Insider) | Bought (not open market) | — |
| May 14, 2026 | Deborah Dunsire (Insider) | Bought (not open market) | — |
| May 14, 2026 | Amrit Ray (Insider) | Bought (not open market) | — |
| May 14, 2026 | Corazon (Corsee) D. Sanders (Insider) | Bought (not open market) | — |
| May 5, 2026 | Eric Crombez (C-suite exec) | Sold | $8.6K |
| May 1, 2026 | Howard Horn (CFO) | Sold | $117K |
| Apr 22, 2026 | Theodore Alan Huizenga (C-suite exec) | Bought (not open market) | — |
| Apr 22, 2026 | Theodore Alan Huizenga (C-suite exec) | Bought (not open market) | — |
| Apr 16, 2026 | Dennis Karl Huang (Insider) | Bought (not open market) | — |
| Apr 16, 2026 | Howard Horn (CFO) | Bought (not open market) | — |
| Apr 16, 2026 | John Richard Pinion (Insider) | Bought (not open market) | — |
Who's trading RARE
- Corazon (Corsee) D. Sanders, Insider: sold $50.1K (1 sale), last Jun 15, 2026
- Karah Herdman Parschauer, C-suite exec: sold $441K (4 sales), last Jun 15, 2026
- Howard Horn, CFO: sold $1.1M (10 sales), last Jun 1, 2026
- Shehnaaz Suliman, Insider: sold $144K (1 sale), last May 18, 2026
- Daniel G Welch, Insider: other filings, last May 14, 2026
- Michael Narachi, Insider: other filings, last May 14, 2026
- Matthew K Fust, Insider: other filings, last May 14, 2026
- Amrit Ray, Insider: other filings, last May 14, 2026
- Deborah Dunsire, Insider: other filings, last May 14, 2026
- Eric Crombez, C-suite exec: sold $169K (2 sales), last May 5, 2026
- Theodore Alan Huizenga, C-suite exec: sold $40.1K (2 sales), last Apr 22, 2026
- John Richard Pinion, Insider: sold $229K (1 sale), last Apr 16, 2026
- Emil D Kakkis, CEO: sold $1.2M (1 sale), last Apr 16, 2026
- Dennis Karl Huang, Insider: other filings, last Apr 16, 2026
- Erik Harris, C-suite exec: sold $240K (1 sale), last Apr 16, 2026
Get free alerts when an insider at Ultragenyx Pharmaceutical Inc files a new trade →